Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1261-1270 of 1772 for

Edit search filters
  1. Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection

    Rochester, MN

  2. Determining the Special Gene Expressions in Patients with Lung Cancer or Mesothelioma

    Rochester, MN

  3. Preclinical drug testing and assay development for lung adenocarcinoma characterized by the expression of ASCL1

    Rochester, MN

  4. informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia

    Jacksonville, FL

  5. A Study to Evaluate Immune Response Changes to Ovarian Cancer During Chemotherapy

    Rochester, MN

  6. Subepithelial Esophageal Lesions: The Mayo Clinic Experience

    Rochester, MN

  7. A Study of Pharmacogenomics Results and Clinical Data of Patients with Chronic Myeloid Leukemia and Lung Cancer to Assess Current and Future Therapeutic Relevance

    Rochester, MN

  8. Analysis Of Letrozole In Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer

    Jacksonville, FL

  9. A Study Investigating Integrated Genomics And Patient-derived Cancer Models

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. A Study To Evaluate The Immune Response To Anti-HER2 Therapies

    Jacksonville, FL

.

Mayo Clinic Footer